Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Complexity of Complement Resistance Factors Expressed by Acinetobacter baumannii Needed for Survival in Human Serum.

Sanchez-Larrayoz AF, Elhosseiny NM, Chevrette MG, Fu Y, Giunta P, Spallanzani RG, Ravi K, Pier GB, Lory S, Maira-Litrán T.

J Immunol. 2017 Oct 15;199(8):2803-2814. doi: 10.4049/jimmunol.1700877. Epub 2017 Aug 30.

2.

Immunization of Mice.

Maira-Litrán T.

Curr Protoc Mol Biol. 2017 Jan 5;117:11.4.1-11.4.11. doi: 10.1002/cpmb.30.

PMID:
28060409
3.

Absence of TLR11 in Mice Does Not Confer Susceptibility to Salmonella Typhi.

Song J, Wilhelm CL, Wangdi T, Maira-Litran T, Lee SJ, Raetz M, Sturge CR, Mirpuri J, Pei J, Grishin NV, McSorley SJ, Gewirtz AT, Bäumler AJ, Pier GB, Galán JE, Yarovinsky F.

Cell. 2016 Feb 25;164(5):827-8. doi: 10.1016/j.cell.2016.02.015. No abstract available.

4.

Alterations in the Staphylococcus epidermidis biofilm transcriptome following interaction with whole human blood.

França A, Carvalhais V, Maira-Litrán T, Vilanova M, Cerca N, Pier G.

Pathog Dis. 2014 Apr;70(3):444-8. doi: 10.1111/2049-632X.12130. Epub 2014 Feb 10.

PMID:
24391077
5.

Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens.

Cywes-Bentley C, Skurnik D, Zaidi T, Roux D, Deoliveira RB, Garrett WS, Lu X, O'Malley J, Kinzel K, Zaidi T, Rey A, Perrin C, Fichorova RN, Kayatani AK, Maira-Litràn T, Gening ML, Tsvetkov YE, Nifantiev NE, Bakaletz LO, Pelton SI, Golenbock DT, Pier GB.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):E2209-18. doi: 10.1073/pnas.1303573110. Epub 2013 May 28.

6.

Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.

Maira-Litrán T, Bentancor LV, Bozkurt-Guzel C, O'Malley JM, Cywes-Bentley C, Pier GB.

PLoS One. 2012;7(9):e43813. doi: 10.1371/journal.pone.0043813. Epub 2012 Sep 6.

7.

Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.

Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litrán T.

Infect Immun. 2012 Oct;80(10):3381-8. doi: 10.1128/IAI.06096-11. Epub 2012 Jul 23.

8.

Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii.

Bentancor LV, Camacho-Peiro A, Bozkurt-Guzel C, Pier GB, Maira-Litrán T.

J Bacteriol. 2012 Aug;194(15):3950-60. doi: 10.1128/JB.06769-11. Epub 2012 May 18.

9.

Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection.

Skurnik D, Davis MR Jr, Benedetti D, Moravec KL, Cywes-Bentley C, Roux D, Traficante DC, Walsh RL, Maira-Litràn T, Cassidy SK, Hermos CR, Martin TR, Thakkallapalli EL, Vargas SO, McAdam AJ, Lieberman TD, Kishony R, Lipuma JJ, Pier GB, Goldberg JB, Priebe GP.

J Infect Dis. 2012 Jun;205(11):1709-18. doi: 10.1093/infdis/jis254. Epub 2012 Mar 23.

10.

Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections.

Bentancor LV, O'Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litrán T.

Infect Immun. 2012 Feb;80(2):651-6. doi: 10.1128/IAI.05653-11. Epub 2011 Nov 21.

11.

Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.

Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB.

Infect Immun. 2011 Aug;79(8):3455-64. doi: 10.1128/IAI.00157-11. Epub 2011 May 31.

12.

Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.

Skurnik D, Merighi M, Grout M, Gadjeva M, Maira-Litran T, Ericsson M, Goldmann DA, Huang SS, Datta R, Lee JC, Pier GB.

J Clin Invest. 2010 Sep;120(9):3220-33. doi: 10.1172/JCI42748. Epub 2010 Aug 25.

13.

Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines.

Campodónico VL, Llosa NJ, Grout M, Döring G, Maira-Litrán T, Pier GB.

Infect Immun. 2010 Feb;78(2):746-55. doi: 10.1128/IAI.00806-09. Epub 2009 Dec 7.

14.

Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens.

Gening ML, Maira-Litrán T, Kropec A, Skurnik D, Grout M, Tsvetkov YE, Nifantiev NE, Pier GB.

Infect Immun. 2010 Feb;78(2):764-72. doi: 10.1128/IAI.01093-09. Epub 2009 Nov 30.

15.

The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation.

Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litrán T.

J Bacteriol. 2009 Oct;191(19):5953-63. doi: 10.1128/JB.00647-09. Epub 2009 Jul 24.

16.

Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria.

Pérez MM, Prenafeta A, Valle J, Penadés J, Rota C, Solano C, Marco J, Grilló MJ, Lasa I, Irache JM, Maira-Litran T, Jiménez-Barbero J, Costa L, Pier GB, de Andrés D, Amorena B.

Vaccine. 2009 Apr 14;27(17):2379-86. doi: 10.1016/j.vaccine.2009.02.005. Epub 2009 Feb 12.

17.

Wall teichoic acids are dispensable for anchoring the PNAG exopolysaccharide to the Staphylococcus aureus cell surface.

Vergara-Irigaray M, Maira-Litrán T, Merino N, Pier GB, Penadés JR, Lasa I.

Microbiology. 2008 Mar;154(Pt 3):865-877. doi: 10.1099/mic.0.2007/013292-0.

18.

Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine.

Cerca N, Jefferson KK, Maira-Litrán T, Pier DB, Kelly-Quintos C, Goldmann DA, Azeredo J, Pier GB.

Infect Immun. 2007 Jul;75(7):3406-13. Epub 2007 Apr 30.

19.

Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.

Cerca N, Maira-Litrán T, Jefferson KK, Grout M, Goldmann DA, Pier GB.

Proc Natl Acad Sci U S A. 2007 May 1;104(18):7528-33. Epub 2007 Apr 19.

20.

Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection.

Kropec A, Maira-Litran T, Jefferson KK, Grout M, Cramton SE, Götz F, Goldmann DA, Pier GB.

Infect Immun. 2005 Oct;73(10):6868-76.

21.

Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.

Maira-Litrán T, Kropec A, Goldmann DA, Pier GB.

Infect Immun. 2005 Oct;73(10):6752-62. Erratum in: Infect Immun. 2005 Nov;73(11):7789.

22.

Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide.

Maira-Litran T, Kropec A, Goldmann D, Pier GB.

Vaccine. 2004 Feb 17;22(7):872-9. Review.

PMID:
15040940
23.

Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus.

Joyce JG, Abeygunawardana C, Xu Q, Cook JC, Hepler R, Przysiecki CT, Grimm KM, Roper K, Ip CC, Cope L, Montgomery D, Chang M, Campie S, Brown M, McNeely TB, Zorman J, Maira-Litrán T, Pier GB, Keller PM, Jansen KU, Mark GE.

Carbohydr Res. 2003 Apr 22;338(9):903-22.

PMID:
12681914
24.

Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide.

Maira-Litrán T, Kropec A, Abeygunawardana C, Joyce J, Mark G 3rd, Goldmann DA, Pier GB.

Infect Immun. 2002 Aug;70(8):4433-40.

25.

The physiology and collective recalcitrance of microbial biofilm communities.

Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW.

Adv Microb Physiol. 2002;46:202-56. Review.

PMID:
12073654
27.

Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm.

Maira-Litrán T, Allison DG, Gilbert P.

J Appl Microbiol. 2000 Feb;88(2):243-7.

28.

Perfused biofilm fermenters.

Allison D, Maira-Litran T, Gilbert P.

Methods Enzymol. 1999;310:232-48. No abstract available.

PMID:
10547797

Supplemental Content

Loading ...
Support Center